Daclizumab
Daclizumab (Zenapax) is a humanized monoclonal antibody that specifically inhibits the alpha subunit of IL-2R-HA. Daclizumab (Zenapax) can inhibit the binding of IL-2 and IL-2R-HA through specific binding to CD25. Daclizumab (Zenapax) studies multiple sclerosis.
Product Specifications
CAS Number
152923-56-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IL Receptor
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
SC216352 10 µg
Retinoblastoma binding protein 1 (ARID4A) (NM_023000) Human 3' UTR Clone
Ask
View Details 
MBS1154051-01 0.02 mg (E-Coli)
Recombinant Yersinia pestis bv. Antiqua Xaa-Pro dipeptidase (pepQ)
Ask
View Details 
MBS1154051-02 0.02 mg (Yeast)
Recombinant Yersinia pestis bv. Antiqua Xaa-Pro dipeptidase (pepQ)
Ask
View Details 
MBS1154051-03 0.1 mg (E-Coli)
Recombinant Yersinia pestis bv. Antiqua Xaa-Pro dipeptidase (pepQ)
Ask
View Details MBS1154051-04 0.1 mg (Yeast)
Recombinant Yersinia pestis bv. Antiqua Xaa-Pro dipeptidase (pepQ)
Ask
View Details